<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>31(3)</volume><submitter>Couteaux C</submitter><pubmed_abstract>After detection of 2 clinical lymphatic filariasis (LF) cases in a postelimination context in 2023 on the island of Futuna (Wallis and Futuna archipelago), the Wallis and Futuna Health Agency conducted a LF prevalence survey in Futuna in May 2024. This cross-sectional study, carried out among schoolchildren &lt;18 years of age, identified 5 children with antigenemia, indicating an estimated antigenemia prevalence in Futuna children nearing 2%. The study also confirmed a spatial cluster of cases in the village of Taoa, where the child antigenemia prevalence reached 7.5% (95% CI 2.1%-18.2%), and demonstrated a link between infection and traditional housing. We observed microfilariae in contact cases during secondary investigations. These findings suggest resurgence of LF in a postelimination context, in which the expected child antigenemia prevalence should not exceed 1%. This situation should prompt a new mass drug administration campaign using triple therapy and the reinforcement of epidemiologic and entomologic surveillance.</pubmed_abstract><journal>Emerging infectious diseases</journal><pagination>488-496</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11878298</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024.</pubmed_title><pmcid>PMC11878298</pmcid><pubmed_authors>Takala G</pubmed_authors><pubmed_authors>Jessop V</pubmed_authors><pubmed_authors>Toa M</pubmed_authors><pubmed_authors>Uhila V</pubmed_authors><pubmed_authors>Worms B</pubmed_authors><pubmed_authors>Couteaux C</pubmed_authors><pubmed_authors>Demaneuf T</pubmed_authors><pubmed_authors>Lie A</pubmed_authors><pubmed_authors>Bien L</pubmed_authors><pubmed_authors>Euller D</pubmed_authors><pubmed_authors>Munoz M</pubmed_authors><pubmed_authors>Selemago MK</pubmed_authors><pubmed_authors>Chesimar S</pubmed_authors><pubmed_authors>Goarant C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024.</name><description>After detection of 2 clinical lymphatic filariasis (LF) cases in a postelimination context in 2023 on the island of Futuna (Wallis and Futuna archipelago), the Wallis and Futuna Health Agency conducted a LF prevalence survey in Futuna in May 2024. This cross-sectional study, carried out among schoolchildren &lt;18 years of age, identified 5 children with antigenemia, indicating an estimated antigenemia prevalence in Futuna children nearing 2%. The study also confirmed a spatial cluster of cases in the village of Taoa, where the child antigenemia prevalence reached 7.5% (95% CI 2.1%-18.2%), and demonstrated a link between infection and traditional housing. We observed microfilariae in contact cases during secondary investigations. These findings suggest resurgence of LF in a postelimination context, in which the expected child antigenemia prevalence should not exceed 1%. This situation should prompt a new mass drug administration campaign using triple therapy and the reinforcement of epidemiologic and entomologic surveillance.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-22T18:38:30.759Z</modification><creation>2025-04-06T02:31:27.608Z</creation></dates><accession>S-EPMC11878298</accession><cross_references><pubmed>40023805</pubmed><doi>10.3201/eid3103.241317</doi></cross_references></HashMap>